Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Dauda Garba has a total of 84 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Polyphenol-Mediated Nanoparticle Synthesis: Insights Into Their Role in Size and Shape Control

    by Abdulrahman Abdulmumin, Dauda Garba, Habib Isa Adamu, Akinpelu Zacheaus


  • Open Access

    In vitro antimalarial activity of phytochemicals from Bombax costatum via inhibition of β-hematin formation

    by Hassan Ali Bila, Garba Dauda, Amina Busola Olorukooba, Dlama Stephen, Khadijah Isa Imam


  • Open Access

    Broad-spectrum antimicrobial activity of a novel phenyl ester and extracts from Nelsonia canescens

    by Abubakar Abdulhameed Abdullahi, Dauda Garba, Yahaya Sani, Mohammed Sule

    Nelsonia canescens is traditionally used to treat infections. This study evaluated its phytochemical composition and antimicrobial activity to validate these ethnomedicinal claims. The methanol extract, its fractions (hexane, chloroform, ethyl acetate, and butanol), and the isolated compound (A1) were screened for phytochemicals and tested against Staphylococcus aureus, Escherichia coli, Salmonella typhi, Candida albicans, and Aspergillus niger using agar diffusion and broth dilution methods, with ciprofloxacin and fluconazole as controls. Phytochemical analysis revealed the presence of flavonoids, saponins, tannins, alkaloids, and cardiac glycosides, which may contribute to the observed bioactivity. Antimicrobial assays showed that the butanol fraction and A1 exhibited strong activity, with zones of inhibition of 30–36 mm (S. aureus) and 28–30 mm (E. coli). The ethyl acetate fraction displayed moderate antifungal effects (17 mm against C. albicans). A1 had the lowest minimum inhibitory concentrations (MIC: 2.5–10 mg/mL) and was bactericidal (MBC: 5–50 mg/mL), comparable to ciprofloxacin (MIC: 1.25–2.5 µg/mL). Non-polar fractions were inactive, while fluconazole was effective only against fungi (MIC/MFC: 1.25–2.5 µg/mL). Overall, polar fractions and A1 showed promising activity against Gram-positive bacteria and C. albicans, although standard drugs were more potent. These findings support the traditional use of N. canescens and highlight its potential as a source of natural antimicrobial agents, with further optimization potentially enhancing its efficacy.

  • Open Access

    In Silico Design of Benzimidazole Derivatives as Dual Inhibitors of AcrB Efflux Pump and NDM-1 to Combat Antibiotic Resistance

    by Yusuf Jimoh, Abdullahi Ahmad, Ummulkhair Sani, Asmau Nasir Hamza, Maryam Abdullahi, Dauda Garba

    Antibiotic resistance poses a critical global health threat, necessitating new strategies to address multidrug-resistant bacteria. This study presents the in silico design and evaluation of five novel benzimidazole derivatives (B1–B5) as dual-action inhibitors targeting both the AcrB efflux pump and NDM-1 carbapenemase two major contributors to antibiotic resistance in Gram-negative pathogens. Computational tools, including Chemdraw, Spartan14, Chimera, Autodock Vina, and Biovia Discovery Studio, were employed for molecular modeling, docking, and visualization of key molecular interactions. All compounds satisfied Lipinski’s rule of five, exhibited high predicted gastrointestinal absorption, and demonstrated favorable pharmacokinetic profiles. Toxicity assessments indicated low to moderate risk, with B4 identified as the safest candidate (LD50: 3420 mg/kg). Molecular docking revealed that B1 and B5 displayed superior binding affinities to NDM-1 (-6.9 and -7.0 kcal/mol, respectively), outperforming the native ligand, while B3 and B4 matched or exceeded the native ligand’s binding to AcrB (-11.1 and -11.0 kcal/mol). Detailed interaction analysis highlighted the importance of hydrogen bonds, pi-alkyl, and pi-pi stacking in stabilizing these complexes. These findings suggest that the designed benzimidazole derivatives hold promise as dual-target inhibitors, offering a potential pathway for developing new therapeutics to combat antibiotic resistance. Further experimental validation is recommended to confirm these computational results and advance these candidates toward clinical application.

  • Open Access

    Molecular docking and dynamics identify novel high-affinity plasmepsin II inhibitors from neem phytochemicals for antimalarial drug development

    by Garba Dauda, Amina Busola Olorukooba, Iyabo Mobolawa Adebisi, Omobolanle Ibukun Ogundele, Murtala Muhammad Jibril, Aiseosa Kingsley Igharo, Jamilu Sani, Walter Mdekera Iorjiim, Okesola Mary Abiola, Abayomi Emmanuel Adegboyega, et al.


  • Open Access

    Structural Insights into Plasmepsin Inhibition by Phenolic Compounds from African Mistletoe (Tapinanthus globiferus) Parasitizing Vitex Doniana

    by Momoh Hassanah, Jimoh Yusuf, Dauda Garba, Yau Jamilu, Mohammed Ibrahim Sule, Yahaya Mohammed Sani

    The parasitic disease malaria necessitates novel drug targets due to increasing Plasmodium falciparum resistance. The purpose of this work was to investigate the antimalarial properties of four metabolites, namely catechin (Y10), catechin-3-gallate (Y11), 4-methoxyphenyl acryl aldehyde (Y12), and 4-hydroxy-3-methoxy acryl aldehyde (Y13), derived from Tapinanthus globiferus, a traditional medicinal plant. Docking studies with important Plasmodium aspartic proteases, Plasmepsins I and II, showed good binding affinities, and Y11 showed the best binding affinity and a critical interaction with the catalytic dyad of Plm-II. The ADMET profile showed drug-likeness with low toxicity. These findings therefore position these metabolites, particularly Y11, as promising lead compounds for the development of antimalarial drugs.

  • Open Access

    A Novel Flavonoid Ester Derivative from the Ethyl Acetate Fraction of Nelsonia canescens: Isolation and Structural Elucidation Techniques

    by Abubakar Abdulhameed Abdullahi, Dauda Garba, Yahaya Mohammed Sani, Mohammed Ibrahim Sule

    The increasing resistance of pathogens to conventional antibiotics has necessitated the search for novel antimicrobial agents from medicinal plants. Nelsonia canescens—a plant traditionally used in Africa and Asia for the management of health issues, such as viral infections, cardiovascular diseases, and inflammation—has been reported to demonstrate antimicrobial activity and has been investigated for its bioactive constituents. The whole plant was collected, air-dried, and extracted using 70% methanol. The crude methanol extract was partitioned into hexane, chloroform, ethyl acetate, and butanol fractions. The ethyl acetate fraction was subjected to column chromatography and gel filtration, leading to the isolation of a compound coded A1. The structure of compound A1 was established through UV, FTIR, NMR (1H, 13C, DEPT, COSY, HMQC, and HMBC), and chemical tests. Compound A1 was identified as a 2*-hydroxy-4*-phenyl-(2**-hydroxy-ethyl)-3′-(4′′′→1′′) glucose-rhamnose-3-hydroxy phenyl ester, a flavonoid derivative. A spectral analysis confirmed its structure, with key signals including olefinic protons (δ 6.30 and 7.62) in the trans-configuration, aromatic protons, and sugar moieties. The compound exhibited a melting point of 105–107 °C and was partially soluble in chloroform but fully soluble in methanol, suggesting that the compound is highly polar in nature. This is the first report on the isolation of the 2*-hydroxy-4*-phenyl-(2**-hydroxy-ethyl)-3′-(4′′′→1′′) glucose-rhamnose-3-hydroxy phenyl ester from Nelsonia canescens, contributing to the taxonomy of the plant. The compound’s structural features suggest potential bioactive properties, warranting further investigation into its pharmacological applications through in vitro and molecular docking studies.


  • Open Access

    Antimalarial Activity of Globimetula oreophila Compounds: In Silico Docking Investigations on Plasmodium falciparum Protease

    by Garba Dauda, Bila Hassan Ali, Bashar Bawa, Maryam Abdullahi, Asmau Nasiru Hamza, Yahaya Mohammed Sani, Muhammad Garba Magaji, Musa Isma’il Abdullahi, Aliyu Muhammad Musa, Halimatu Sadiya Hassan

    Malaria remains a major global health challenge due to its high morbidity and mortality, further complicated by growing antimalarial drug resistance. Natural products are being increasingly explored as potential sources of new therapies, with malarial proteases emerging as promising targets due to their essential roles in parasite development, invasion, egress, and hemoglobin degradation. This study evaluates the inhibitory potential of five compounds, quercetrin (DG1), dihydrostilbene (DG2), 4′-methoxy-isoliquiritigenin (DG3), stigmasterol (DG4), and quercetin (DG5), isolated from Globimetula oreophila leaves, using in silico docking against Plasmodium falciparum enzymes. Targets included falcipain-2 and falcipain-3 (cysteine proteases), SERA5 (hemoglobin-processing enzyme), PfDHFR-TS (bifunctional enzyme), and PfCDPK2 (kinase). Docking revealed strong binding affinities through hydrogen bonds, van der Waals forces, and hydrophobic interactions. DG4 showed a high affinity for PfDHFR (-10.3 kcal/mol), comparable to cycloguanil (-10.7 kcal/mol), while DG1 bound firmly to falcipain-2 (-7.9 kcal/mol), falcipain-3 (-7.5 kcal/mol), and PfCDPK2 (-9.0 kcal/mol). Binding to SERA5 ranged from -6.0 to -6.8 kcal/mol. These findings suggest that the tested compounds may act as inhibitors of vital P. falciparum enzymes, holding promise for the development of antimalarial drugs.


  • Open Access

    Exploring the Anti-Malarial Potential of Terminalia brownii Fresen: A Phytochemical and Biological Activity Study

    by Tawakaltu Omolara Tijani, Akeem Ayodele Olaiya, Dauda Garba, Ibrahim Atiku, Muhammed Ibrahim Sule

    Terminalia brownii is a widely distributed African tree traditionally used to treat ailments such as cough, malaria, hepatitis, and microbial infections. The growing resistance of Plasmodium falciparum to Artemisinin combination therapy and other antimalarial drugs highlights the need for new therapies with improved potency and fewer side effects. This study analyzed the phytochemical constituents and antiplasmodial activity of T. brownii leaf extracts. The leaves were air-dried, powdered, and macerated in 70% methanol, followed by fractionation with n-hexane, chloroform, and ethyl acetate. Qualitative analysis of the methanol crude extract (MCE) revealed tannins, flavonoids, alkaloids, triterpenes, steroids, saponins, phenols, and cardiac glycosides, but not anthraquinones. Quantitative analysis showed phenols (195.45 mg/g), tannins (156.10 mg/g), and flavonoids (135.10 mg/g) as the most abundant. The ethyl acetate fraction contained phenols (103 mg/g) and tannins (69.56 mg/g) but lacked steroids and triterpenes. Antiplasmodial activity was evaluated in Plasmodium berghei-infected mice. The LD50 of the crude extract exceeded 5000 mg/kg, and significant dose-dependent suppression of parasitemia (p<0.05) was observed at 250, 500, and 1000 mg/kg. These findings support the traditional use of T. brownii against malaria and encourage further studies on its bioactive fractions and compounds.